Bank of America’s Akari Therapeutics AKTX Stock Holding History

Bank of America’s Portfolio AKTX Stock Details AKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$118	–	5732
2025 Q4	$118	Buy	10 +6	+150%	+$139	﹤0.01%	6796
2025 Q3	$152	Hold	4	–	–	﹤0.01%	7774
2025 Q2	$175	Hold	4	–	–	﹤0.01%	7864
2025 Q1	$186	Hold	4	–	–	﹤0.01%	7703
2024 Q4	$183	Hold	4	–	–	﹤0.01%	7610
2024 Q3	$442	Hold	4	–	–	﹤0.01%	7404
2024 Q2	$405	Hold	4	–	–	﹤0.01%	7394
2024 Q1	$280	Hold	4	–	–	﹤0.01%	7325
2023 Q4	$468	Hold	4	–	–	﹤0.01%	7289
2023 Q3	$592	Hold	4	–	–	﹤0.01%	7295
2023 Q2	$510	Hold	4	–	–	﹤0.01%	7312
2023 Q1	$543	Hold	4	–	–	﹤0.01%	7362
2022 Q4	$1.41K	Hold	4	–	–	﹤0.01%	7293
2022 Q3	$2K	Hold	4	–	–	﹤0.01%	7550
2022 Q2	$3K	Hold	4	–	–	﹤0.01%	7697
2022 Q1	$4K	Hold	4	–	–	﹤0.01%	7924
2021 Q4	$4K	Hold	4	–	–	﹤0.01%	7865
2021 Q3	$5K	Hold	4	–	–	﹤0.01%	7721
2021 Q2	$5K	Hold	4	–	–	﹤0.01%	7416
2021 Q1	$8K	Hold	4	–	–	﹤0.01%	7050
2020 Q4	$6K	Hold	4	–	–	﹤0.01%	6797
2020 Q3	$5K	Hold	4	–	–	﹤0.01%	6578
2020 Q2	$7K	Hold	4	–	–	﹤0.01%	6509
2020 Q1	$5K	Hold	4	–	–	﹤0.01%	6491
2019 Q4	$5K	Hold	4	–	–	﹤0.01%	6756
2019 Q3	$5K	Buy	+4	New	+$6.12K	﹤0.01%	6840
2016 Q1	–	Sell	-2	Closed	-$22K	–	6964
2015 Q4	$22K	Buy	+2	New	+$29.7K	﹤0.01%	6383

Other funds holding AKTX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return

Bank of America's AKTX Position: Q1 2026 in Review

Bank of America sold out of Akari Therapeutics (AKTX) in Q1 2026, closing a stake of 10 shares — an estimated $118 sold.

Bank of America first reported a position in AKTX in Q4 2015 and held it in 27 quarters. The position peaked at $22K in Q4 2015. 6 funds tracked by Wall St. Rank hold AKTX as of Q1 2026.

Bank of America reported no remaining Akari Therapeutics position as of Q1 2026 after selling out during the quarter.
Bank of America sold 10 Akari Therapeutics shares in Q1 2026, an estimated $118.
Bank of America first reported a position in Akari Therapeutics in Q4 2015 and held it in 27 quarters.
Bank of America's Akari Therapeutics position peaked at $22K in Q4 2015.
6 funds tracked by Wall St. Rank held Akari Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.